These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo. Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells. Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479 [TBL] [Abstract][Full Text] [Related]
4. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882 [TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278 [TBL] [Abstract][Full Text] [Related]
7. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030 [TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848 [TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma. Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839 [TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740 [TBL] [Abstract][Full Text] [Related]
12. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681 [TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro. Zhang JF; Liu JJ; Lu MQ; Cai CJ; Yang Y; Li H; Xu C; Chen GH Transpl Immunol; 2007 Apr; 17(3):162-8. PubMed ID: 17331842 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Ghous Z; Akhter J; Pourgholami MH; Morris DL Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661 [TBL] [Abstract][Full Text] [Related]
15. MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway. Ying M; Tu C; Ying H; Hu Y; He Q; Yang B J Pharmacol Exp Ther; 2008 Jun; 325(3):758-65. PubMed ID: 18323457 [TBL] [Abstract][Full Text] [Related]
16. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma. Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097 [TBL] [Abstract][Full Text] [Related]
17. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692 [TBL] [Abstract][Full Text] [Related]
18. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415 [TBL] [Abstract][Full Text] [Related]
19. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation. Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma. Esposito V; Palescandolo E; Spugnini EP; Montesarchio V; De Luca A; Cardillo I; Cortese G; Baldi A; Chirianni A Clin Cancer Res; 2006 Apr; 12(8):2634-9. PubMed ID: 16638877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]